{"id":90551,"date":"2020-12-09T11:00:12","date_gmt":"2020-12-09T00:00:12","guid":{"rendered":"https:\/\/www.fnarena.com\/?p=90551"},"modified":"2020-12-09T11:00:14","modified_gmt":"2020-12-09T00:00:14","slug":"australian-broker-call-extra-edition-dec-09-2020","status":"publish","type":"post","link":"https:\/\/staging.fnarena.com\/index.php\/2020\/12\/09\/australian-broker-call-extra-edition-dec-09-2020\/","title":{"rendered":"Australian Broker Call *Extra* Edition &#8211; Dec 09, 2020"},"content":{"rendered":"<p><strong>An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed&nbsp;equities.<\/strong><\/p>\n<p>In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena&nbsp;has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed&nbsp;stocks, also enlarging the number of stocks that make up the FNArena&nbsp;universe.<\/p>\n<p>One key difference is the *Extra* Edition will not be updated daily, but merely &quot;regularly&quot; depending on availability&nbsp;of&nbsp;suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.<\/p>\n<p>Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication&nbsp;may not be up to date, or yet awaiting another update by FNArena&#039;s&nbsp;team of journalists.<\/p>\n<p>Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.<\/p>\n<p>The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.<\/p>\n<p>The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.<\/p>\n<p><strong>COMPANIES DISCUSSED IN THIS ISSUE<\/strong><\/p>\n<p>Click on a symbol for fast access.<br \/>The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)<\/p>\n<p><a href=\"#AMA\" style=\"font-weight:bold\">AMA<\/a>&nbsp;&nbsp; <a href=\"#APT\" style=\"font-weight:bold\">APT<\/a>&nbsp;&nbsp; <a href=\"#AX1\" style=\"font-weight:bold\">AX1<\/a>&nbsp;&nbsp; <a href=\"#BWX\" style=\"font-weight:bold\">BWX<\/a>&nbsp;&nbsp; <a href=\"#CAJ\" style=\"font-weight:bold\">CAJ&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#ELD\" style=\"font-weight:bold\">ELD&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#HLO\" style=\"font-weight:bold\">HLO<\/a>&nbsp;&nbsp; <a href=\"#IAG\" style=\"font-weight:bold\">IAG<\/a>&nbsp;&nbsp; <a href=\"#IFL\" style=\"font-weight:bold\">IFL<\/a>&nbsp;&nbsp; <a href=\"#IPH\" style=\"font-weight:bold\">IPH<\/a>&nbsp;&nbsp; <a href=\"#JAN\" style=\"font-weight:bold\">JAN<\/a>&nbsp;&nbsp; <a href=\"#LBL\" style=\"font-weight:bold\">LBL<\/a>&nbsp;&nbsp; <a href=\"#LBY\" style=\"font-weight:bold\">LBY<\/a>&nbsp;&nbsp; <a href=\"#MYX\" style=\"font-weight:bold\">MYX<\/a>&nbsp;&nbsp; <a href=\"#NAN\" style=\"font-weight:bold\">NAN<\/a>&nbsp;&nbsp; <a href=\"#NWL\" style=\"font-weight:bold\">NWL<\/a>&nbsp;&nbsp; <a href=\"#NXS\" style=\"font-weight:bold\">NXS<\/a>&nbsp;&nbsp; <a href=\"#PPS\" style=\"font-weight:bold\">PPS<\/a>&nbsp;&nbsp; <a href=\"#TNE\" style=\"font-weight:bold\">TNE<\/a>&nbsp;&nbsp; <a href=\"#UWL\" style=\"font-weight:bold\">UWL<\/a>&nbsp;&nbsp; <a href=\"#WSP\" style=\"font-weight:bold\">WSP<\/a>&nbsp;&nbsp; <a href=\"#Z1P\" style=\"font-weight:bold\">Z1P<\/a>&nbsp;&nbsp;<\/p>\n<h2><a name=\"AMA\">AMA<\/a>&nbsp;&nbsp;&nbsp; AMA GROUP LIMITED<\/h2>\n<p><strong>Automobiles &amp; Components &#8211; Overnight Price: $0.81 <\/strong><\/p>\n<p>Bell Potter rates ((AMA)) as Buy (1) &#8211;<\/p>\n<p>AMA Group&nbsp;has sold its parts business &#8211;&nbsp;ACAD &#8211;&nbsp;for $70m. According to the company&#039;s latest update, the first quarter was ahead of expectations with operations in Victoria expected to return to full capacity by the end of December.<\/p>\n<p>Bell Potter is pleased with the decision to sell the parts business given it has reduced&nbsp;the net debt below -$200m, effectively ensuring&nbsp;the covenant test on December 31 will be met. Also, the sale makes the company a pure-play in vehicle panel repair which may make it more attractive from a takeover perspective.<\/p>\n<p>The Buy rating is unchanged and the target price is increased to $1 from $0.95.<\/p>\n<p>This report was published on November 23, 2020.<\/p>\n<p>Target price is <strong>$1.00<\/strong> Current Price is <strong>$0.81 <\/strong> Difference: <strong>$0.19<\/strong><br \/>If <strong>AMA<\/strong> meets the Bell Potter target it will return approximately <strong> 23%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>0.20<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>405.00<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>3.10<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>26.13<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"APT\">APT<\/a>&nbsp;&nbsp;&nbsp; AFTERPAY LIMITED<\/h2>\n<p><strong>Business &amp; Consumer Credit &#8211; Overnight Price: $95.68 <\/strong><\/p>\n<p>Wilsons rates ((APT)) as Overweight (1) &#8211;<\/p>\n<p>Wilsons believes the UK Lockdown 2.0 maybe another shot to the arm&nbsp;for Afterpay. The presence of tailwinds bodes well for a strong second quarter in the UK and therefore Afterpay UK.<\/p>\n<p>Additionally, evidence suggests there may also be a pull-forward of purchase behaviour in the UK in the lead-up to Christmas, with recent consumer polls suggesting a preference to having December &ldquo;locked down&rdquo; rather than the structured tier-based restrictions proposed by the Johnson government.<\/p>\n<p>Overweight rating retained with a target price of $113.94.<\/p>\n<p>This report was published on November 23, 2020.<\/p>\n<p>Target price is <strong>$113.94<\/strong> Current Price is <strong>$95.68 <\/strong> Difference: <strong>$18.26<\/strong><br \/>If <strong>APT<\/strong> meets the Wilsons target it will return approximately <strong> 19%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$98.36<\/strong>, suggesting upside of <strong>2.8%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>11.20<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>854.29<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>12.4<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>771.6<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>28.90<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>331.07<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>46.8<\/strong>, implying annual growth of <strong>277.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>204.4<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"AX1\">AX1<\/a>&nbsp;&nbsp;&nbsp; ACCENT GROUP LIMITED<\/h2>\n<p><strong>Apparel &amp; Footwear &#8211; Overnight Price: $2.19 <\/strong><\/p>\n<p>Bell Potter rates ((AX1)) as Buy (1) &#8211;<\/p>\n<p>Accent Group&#039;s latest trading update covering the first 20 weeks of FY21 showed strong like for like sales growth, lifting&nbsp;by 15.7% (excluding store closures). Digital sales were up 129% versus last year. and continue&nbsp;to grow at more than 100%.<\/p>\n<p>Bell Potter notes the company&#039;s growth plan is progressing&nbsp;strongly with store growth higher than expected at 66 net new stores. The broker considers the update is solid with all retail banners performing well with The Athlete&#039;s Foot and&nbsp;Skechers&nbsp;being the outperformers.<\/p>\n<p>&nbsp;Bell Potter retains its Buy rating with the target price rising to $2.15 from $1.85.<\/p>\n<p>This report was published&nbsp;on November 23, 2020.<\/p>\n<p>Target price is <strong>$2.15<\/strong> Current Price is <strong>$2.19 <\/strong> Difference: <strong>minus $0.04<\/strong> (current price is over target).<br \/>If <strong>AX1<\/strong> meets the Bell Potter target it will return approximately <strong>minus 2%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$1.98<\/strong>, suggesting downside of <strong>-9.4%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>11.20<\/strong> cents and EPS of <strong>13.10<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.11%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>16.72<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>11.5<\/strong>, implying annual growth of <strong>11.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>9.3<\/strong>, implying a prospective dividend yield of <strong>4.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>19.0<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>11.10<\/strong> cents and EPS of <strong>13.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.07%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>15.87<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>11.3<\/strong>, implying annual growth of <strong>-1.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>9.2<\/strong>, implying a prospective dividend yield of <strong>4.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>19.4<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"BWX\">BWX<\/a>&nbsp;&nbsp;&nbsp; BWX LTD<\/h2>\n<p><strong>Household &amp; Personal Products &#8211; Overnight Price: $3.98 <\/strong><\/p>\n<p>Moelis rates ((BWX)) as Buy (1) &#8211;<\/p>\n<p>BWX has struck a new partnership with The Hut Group to accelerate a direct to consumer strategy in Europe and Asia. Moelis believes this makes strategic sense.<\/p>\n<p>Management reaffirmed guidance for at least 10% revenue and earnings (EBITDA) growth, with a second half skew due to covid impacts in the first half.<\/p>\n<p>The Buy rating is unchanged and the target price is&nbsp;$4.87.<\/p>\n<p>This report was published on November 18, 2020.<\/p>\n<p>Target price is <strong>$4.87<\/strong> Current Price is <strong>$3.98 <\/strong> Difference: <strong>$0.89<\/strong><br \/>If <strong>BWX<\/strong> meets the Moelis target it will return approximately <strong> 22%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY21<\/strong> dividend of <strong>4.00<\/strong> cents and EPS of <strong>12.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.01%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>31.34<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY22<\/strong> dividend of <strong>5.70<\/strong> cents and EPS of <strong>17.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.43%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>22.36<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"CAJ\">CAJ<\/a>&nbsp;&nbsp;&nbsp; CAPITOL HEALTH LIMITED<\/h2>\n<p><strong>Healthcare services &#8211; Overnight Price: $0.28 <\/strong><\/p>\n<p>Shaw and Partners rates ((CAJ)) as Buy (1) &#8211;<\/p>\n<p>Capitol Health has announced the acquisition of Direct Radiology, a Victorian diagnostic imaging provider which has two highly profitable established clinics and a newly opened greenfields site.&nbsp;<\/p>\n<p>Total initial consideration is $12m and Shaw and Partners estimate FY22 accretion of around 5%.&nbsp;<\/p>\n<p>The broker believes the company is undervalued, the balance sheet is under-geared and there is latent value in strategic holdings.<\/p>\n<p>The Buy rating is unchanged and the target increases to $0.32 from $0.31.<\/p>\n<p>This report was published on November 17, 2020.<\/p>\n<p>Target price is <strong>$0.32<\/strong> Current Price is <strong>$0.28 <\/strong> Difference: <strong>$0.04<\/strong><br \/>If <strong>CAJ<\/strong> meets the Shaw and Partners target it will return approximately <strong> 14%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.80<\/strong> cents and EPS of <strong>1.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.86%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>20.00<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>1.00<\/strong> cents and EPS of <strong>2.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.57%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.00<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.8<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Wilsons rates ((CAJ)) as Market Weight (3) &#8211;<\/p>\n<p>Wilsons maintains its Market Weight rating on Capitol Health with the target rising to $0.28 from $0.23.<\/p>\n<p>Capitol Health&#039;s&nbsp;recovery from the pandemic is ahead of the broker&#039;s estimates and the acquisition of Direct Radiology is expected to be earnings accretive from FY22. The diagnostic imaging provider has $120m in balance sheet capacity.<\/p>\n<p>With recent high-value M&amp;A activity in the sector, the focus of growth may shift&nbsp;towards internal projects.<\/p>\n<p>This report was published on November 23, 2020.<\/p>\n<p>Target price is <strong>$0.28<\/strong> Current Price is <strong>$0.28 <\/strong> Difference: <strong>$0<\/strong><br \/>If <strong>CAJ<\/strong> meets the Wilsons target it will return approximately <strong> 0%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.50<\/strong> cents and EPS of <strong>1.30<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.79%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>21.54<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>1.00<\/strong> cents and EPS of <strong>1.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.57%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>16.47<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.8<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"ELD\">ELD<\/a>&nbsp;&nbsp;&nbsp; ELDERS LIMITED<\/h2>\n<p><strong>Agriculture &#8211; Overnight Price: $10.29 <\/strong><\/p>\n<p>Bell Potter rates ((ELD)) as Buy (1) &#8211;<\/p>\n<p>Elders&nbsp;reported a FY20 underlying profit 5% ahead of Bell&nbsp;Potter&#039;s forecast. The result was considered&nbsp;primarily driven by market share gains in livestock and a higher contribution from real estate.<\/p>\n<p>The broker&nbsp;maintains a&nbsp;Buy rating with the target price increasing to $13.30 from&nbsp;$12.25,&nbsp;reflecting a lower net debt position and lower weighted average cost of capital (WACC) hurdle.<\/p>\n<p>The report was published on November 17,&nbsp;2020.<\/p>\n<p>Target price is <strong>$13.30<\/strong> Current Price is <strong>$10.29 <\/strong> Difference: <strong>$3.01<\/strong><br \/>If <strong>ELD<\/strong> meets the Bell Potter target it will return approximately <strong> 29%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$12.89<\/strong>, suggesting upside of <strong>25.2%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in September.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>25.00<\/strong> cents and EPS of <strong>78.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.43%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>13.06<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>79.1<\/strong>, implying annual growth of <strong>-0.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>25.8<\/strong>, implying a prospective dividend yield of <strong>2.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>13.0<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>28.00<\/strong> cents and EPS of <strong>85.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.72%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>11.99<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>86.0<\/strong>, implying annual growth of <strong>8.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>28.1<\/strong>, implying a prospective dividend yield of <strong>2.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>12.0<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Wilsons rates ((ELD)) as Underweight (5) &#8211;<\/p>\n<p>Wilsons considers Elders&#039; FY20 result was very strong with earnings (EBIT) growth of 68%, driven by the AIRR acquisition, improved winter&nbsp;cropping activity and stronger livestock prices.<\/p>\n<p>The broker highlights&nbsp;adjusted cash conversion improved to 85% from 46% in the previous corresponding period,&nbsp;and a&nbsp;historical average level of around&nbsp;93%.<\/p>\n<p>Wilsons assumes&nbsp;growth in FY21 is partly constrained by lower winter cropping activity (return to normal season), lower livestock prices (off a higher base), and higher cost growth.<\/p>\n<p>The Underweight rating is unchanged and the target price is decreased to $8.57 from $8.75.<\/p>\n<p>This report was published on November 17,&nbsp;2020.<\/p>\n<p>Target price is <strong>$8.57<\/strong> Current Price is <strong>$10.29 <\/strong> Difference: <strong>minus $1.72<\/strong> (current price is over target).<br \/>If <strong>ELD<\/strong> meets the Wilsons target it will return approximately <strong>minus 17%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$12.89<\/strong>, suggesting upside of <strong>25.2%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in September.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY21<\/strong> dividend of <strong>26.00<\/strong> cents and EPS of <strong>71.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.53%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.35<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>79.1<\/strong>, implying annual growth of <strong>-0.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>25.8<\/strong>, implying a prospective dividend yield of <strong>2.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>13.0<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>30.00<\/strong> cents and EPS of <strong>74.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.92%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>13.83<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>86.0<\/strong>, implying annual growth of <strong>8.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>28.1<\/strong>, implying a prospective dividend yield of <strong>2.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>12.0<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"HLO\">HLO<\/a>&nbsp;&nbsp;&nbsp; HELLOWORLD TRAVEL LIMITED<\/h2>\n<p><strong>Travel, Leisure &amp; Tourism &#8211; Overnight Price: $2.79 <\/strong><\/p>\n<p>Bell Potter rates ((HLO)) as Hold (3) &#8211;<\/p>\n<p>Helloworld Travel has acquired the cruise wholesaling specialist, CruiseCo, expected to be complementary to Helloworld&#039;s existing wholesale cruise business, Seven Oceans Cruising.<\/p>\n<p>The company&nbsp;also renewed its partnership with Qantas to sell the national carrier&rsquo;s fares and products until 2023. Bell Potter notes&nbsp;the contract indicates the importance of the travel agent distribution channel and its ability to drive volume and impact market share.<\/p>\n<p>Helloworld Travel gives a diversified exposure to a rebound in travel bookings and Bell Potter believes the company is well placed to deal with the prolonged downturn given its current liquidity position and restructured cost-base.<\/p>\n<p>Even so, the broker at this stage prefers companies with a direct sales model or those with larger corporate businesses that are leveraged to a rebound in domestic travel.<\/p>\n<p>The Hold rating is unchanged and the target increased to $2.70 from $1.95.<\/p>\n<p>This report was published on November 23, 2020.<\/p>\n<p>Target price is <strong>$2.70<\/strong> Current Price is <strong>$2.79 <\/strong> Difference: <strong>minus $0.09<\/strong> (current price is over target).<br \/>If <strong>HLO<\/strong> meets the Bell Potter target it will return approximately <strong>minus 3%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 28.30<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 9.86<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>7.30<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>38.22<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"IAG\">IAG<\/a>&nbsp;&nbsp;&nbsp; INSURANCE AUSTRALIA GROUP LIMITED<\/h2>\n<p><strong>Insurance &#8211; Overnight Price: $5.22 <\/strong><\/p>\n<p>Bell Potter rates ((IAG)) as Hold (3) &#8211;<\/p>\n<p>Post the unfavourable ruling on the business interruption (BI) insurance test case, Insurance Australia Group has decided to increase total the BI provisions to -$865m post-tax and raise up to $750m in new equity capital to strengthen its CET1 ratio.<\/p>\n<p>Including the -$60m post-tax provision taken in FY20, the impact on the first half cash net profit would be around $805m, assesses Bell Potter.<\/p>\n<p>The insurer has also identified items like higher customer refunds and prior period reserve strengthening that may further impact the net profit in the first half by around -$50-65m post-tax.<\/p>\n<p>While the broker had previously forecast the insurer resuming&nbsp;dividend payments, this is unlikely now given its forecast statutory loss in the first half.<\/p>\n<p>Hold rating is retained with the target price dropping to $5.20 from $5.60.<\/p>\n<p>This report was published on November 23, 2020.<\/p>\n<p>Target price is <strong>$5.20<\/strong> Current Price is <strong>$5.22 <\/strong> Difference: <strong>minus $0.02<\/strong> (current price is over target).<br \/>If <strong>IAG<\/strong> meets the Bell Potter target it will return approximately <strong>minus 0%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$5.46<\/strong>, suggesting upside of <strong>4.5%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>9.00<\/strong> cents and EPS of <strong>minus 5.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.72%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 104.40<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>6.6<\/strong>, implying annual growth of <strong>-65.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>16.3<\/strong>, implying a prospective dividend yield of <strong>3.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>79.1<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>21.00<\/strong> cents and EPS of <strong>32.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.02%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>16.31<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>31.9<\/strong>, implying annual growth of <strong>383.3%<\/strong>.<br \/>Current consensus DPS estimate is <strong>25.4<\/strong>, implying a prospective dividend yield of <strong>4.9%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>16.4<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.4<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"IFL\">IFL<\/a>&nbsp;&nbsp;&nbsp; IOOF HOLDINGS LIMITED<\/h2>\n<p><strong>Wealth Management &amp; Investments &#8211; Overnight Price: $3.74 <\/strong><\/p>\n<p>Bell Potter rates ((IFL)) as Downgrade to Hold from Buy (3) &#8211;<\/p>\n<p>Bell Potter downgrades its recommendation to Hold from Buy given the recent short-term run in the share price. The target rises to $3.70 from $3.45.<\/p>\n<p>The broker is cautious given the significant amount of work IOOF Holdings has before it with two major integrations in a sector that is going through a structural shift.&nbsp;<\/p>\n<p>IOOF is in the middle of seeking approvals for its $1,440m acquisition of National Australia Bank&#039;s ((NAB)) MLC wealth business.<\/p>\n<p>Bell Potter is concerned about significant balance sheet demands over the year ahead, including the ANZ wealth integration costs, NAB MLC integration costs, ongoing remediation program, compliance one-off costs and the additional debt required to close the MLC deal.<\/p>\n<p>This report was published on November 25, 2020.<\/p>\n<p>Target price is <strong>$3.70<\/strong> Current Price is <strong>$3.74 <\/strong> Difference: <strong>minus $0.04<\/strong> (current price is over target).<br \/>If <strong>IFL<\/strong> meets the Bell Potter target it will return approximately <strong>minus 1%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$4.58<\/strong>, suggesting upside of <strong>22.3%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>15.00<\/strong> cents and EPS of <strong>22.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.01%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>16.70<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>30.2<\/strong>, implying annual growth of <strong>-28.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>22.6<\/strong>, implying a prospective dividend yield of <strong>6.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>12.4<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>22.00<\/strong> cents and EPS of <strong>33.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.88%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>11.03<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>31.3<\/strong>, implying annual growth of <strong>3.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>24.0<\/strong>, implying a prospective dividend yield of <strong>6.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>11.9<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"IPH\">IPH<\/a>&nbsp;&nbsp;&nbsp; IPH LIMITED<\/h2>\n<p><strong>Legal &#8211; Overnight Price: $6.67 <\/strong><\/p>\n<p>Canaccord Genuity rates ((IPH)) as Buy (1) &#8211;<\/p>\n<p>Canaccord Genuity considered IPH shares an ideal market hedge over the last nine months, expected to outperform&nbsp;on the way down and then rise again as the market rallies. Things didn&#039;t work out with the shares falling almost all the way down in March but lagging&nbsp;on the rebound.<\/p>\n<p>Not boasting a strong technology story, IPH has underperformed the Small Ords Index by -25% since the beginning of March although the company reinforced the resilience of the business in its AGM.<\/p>\n<p>Buy rating is retained with a target of $9.50.<\/p>\n<p>This report was published on November 20, 2020.<\/p>\n<p>Target price is <strong>$9.50<\/strong> Current Price is <strong>$6.67 <\/strong> Difference: <strong>$2.83<\/strong><br \/>If <strong>IPH<\/strong> meets the Canaccord Genuity target it will return approximately <strong> 42%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY21<\/strong> dividend of <strong>29.00<\/strong> cents and EPS of <strong>36.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.35%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>18.53<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>32.00<\/strong> cents and EPS of <strong>40.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.80%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>16.67<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"JAN\">JAN<\/a>&nbsp;&nbsp;&nbsp; JANISON EDUCATION GROUP LIMITED<\/h2>\n<p><strong>Education &amp; Tuition &#8211; Overnight Price: $0.55 <\/strong><\/p>\n<p>Bell Potter rates ((JAN)) as Upgrade to Buy from Hold (1) &#8211;<\/p>\n<p>Janison Education&#039;s growth outlook is expected to benefit from key drivers including growth in platform revenue, strong execution from the Educational Assessment business acquired in March and new revenue opportunities from the partnership with LMS provider, D2L.&nbsp;<\/p>\n<p>Bell Potter notes Janison Education has been successful in expanding its gross margin profile led by growth from higher-margin platform revenues.&nbsp;The broker believes the company is well placed to deliver on its growth strategy over the next 6-12 months.<\/p>\n<p>Bell Potter upgrades its recommendation to Buy from Hold with the target price rising to $0.45 from $0.42.<\/p>\n<p>This report was published on November 25, 2020.<\/p>\n<p>Target price is <strong>$0.45<\/strong> Current Price is <strong>$0.55 <\/strong> Difference: <strong>minus $0.1<\/strong> (current price is over target).<br \/>If <strong>JAN<\/strong> meets the Bell Potter target it will return approximately <strong>minus 18%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>0.10<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>550.00<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>1.20<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>45.83<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"LBL\">LBL<\/a>&nbsp;&nbsp;&nbsp; LASERBOND LIMITED<\/h2>\n<p><strong>Mining Sector Contracting &#8211; Overnight Price: $0.68 <\/strong><\/p>\n<p>CCZ Equities rates ((LBL)) as Buy (1) &#8211;<\/p>\n<p>CCZ Equities initiates coverage on Laserbond with a Buy rating and a target price of $1.08.<\/p>\n<p>Laserbond reduces the maintenance costs for critical machinery via a process called laser cladding which enables the machinery to be protected from harsh conditions and improves its&nbsp;wear life.<\/p>\n<p>With abrasion wear estimated to cost up to 4% of Australia&#039;s GDP, amounting to circa $30bn per annum, CCZ Equities believes there is significant potential in the industry.<\/p>\n<p>Also, Laserbond&nbsp;is working in an industry with high barriers to entry, and has strong growth prospects backed by the company&rsquo;s intellectual property that has been built over two decades of experience.<\/p>\n<p>The broker expects considerable profit growth in FY21.&nbsp;<\/p>\n<p>This report was published on November 11, 2020.<\/p>\n<p>Target price is <strong>$1.08<\/strong> Current Price is <strong>$0.68 <\/strong> Difference: <strong>$0.4<\/strong><br \/>If <strong>LBL<\/strong> meets the CCZ Equities target it will return approximately <strong> 59%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>CCZ Equities forecasts a full year <strong>FY21<\/strong> dividend of <strong>1.33<\/strong> cents and EPS of <strong>4.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.96%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>15.11<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>CCZ Equities forecasts a full year <strong>FY22<\/strong> dividend of <strong>1.77<\/strong> cents and EPS of <strong>5.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.60%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>11.53<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"LBY\">LBY<\/a>&nbsp;&nbsp;&nbsp; LAYBUY GROUP HOLDINGS LIMITED<\/h2>\n<p><strong>Overnight Price: $1.31 <\/strong><\/p>\n<p>Bell Potter rates ((LBY)) as Buy (1) &#8211;<\/p>\n<p>Laybuy&nbsp;Group Holdings&#039; first-half&nbsp;operating income was -NZ$8.1m, mostly in line with Bell Potter&#039;s forecast. October&#039;s gross merchant value (GMV) was up by 164% versus last year with November tracking at 175%.<\/p>\n<p>The growth was led by improving bad debts and propelling its net transaction margin to 1.7% in the first half from -0.6% in the second half of FY20.<\/p>\n<p>Despite this, the group continues to &quot;fly under the radar&quot;. The broker argues the group deserves more attention at the current levels given its significant growth against many of the peers.<\/p>\n<p>Bell Potter retains its Buy rating with a target of $3.00.<\/p>\n<p>This report was published on November 24, 2020.<\/p>\n<p>Target price is <strong>$3.00<\/strong> Current Price is <strong>$1.31 <\/strong> Difference: <strong>$1.69<\/strong><br \/>If <strong>LBY<\/strong> meets the Bell Potter target it will return approximately <strong> 129%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in March.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 7.40<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 17.70<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 6.10<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 21.48<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"MYX\">MYX<\/a>&nbsp;&nbsp;&nbsp; MAYNE PHARMA GROUP LIMITED<\/h2>\n<p><strong>Pharmaceuticals &amp; Biotech\/Lifesciences &#8211; Overnight Price: $0.37 <\/strong><\/p>\n<p>Bell Potter rates ((MYX)) as Hold (3) &#8211;<\/p>\n<p>Mayne Pharma&nbsp;Group&#039;s four-month year to date update shows revenues were -9% lower relative to Bell Potter&#039;s expectation although operating income was slightly higher than last year.<\/p>\n<p>Bell Potter cautions the ongoing revenue decline in the core generics business is not sustainable and the group needs meaningful revenue growth from its two new women&rsquo;s health products and Tolsura.<\/p>\n<p>The progress of both Nextstellis and Nuvaring down the regulatory pathway are crucial for long term earnings growth and to restore some market confidence in the company, adds the broker.<\/p>\n<p>Bell Potter maintains its Hold rating with the target price rising to $0.34 from $0.32.<\/p>\n<p>This report was published on November 25, 2020.<\/p>\n<p>Target price is <strong>$0.34<\/strong> Current Price is <strong>$0.37 <\/strong> Difference: <strong>minus $0.03<\/strong> (current price is over target).<br \/>If <strong>MYX<\/strong> meets the Bell Potter target it will return approximately <strong>minus 8%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$0.37<\/strong>, suggesting downside of <strong>-0.7%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>2.80<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>13.21<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>-0.7<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>N\/A<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>2.60<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.23<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>1.9<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>19.5<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"NAN\">NAN<\/a>&nbsp;&nbsp;&nbsp; NANOSONICS LIMITED<\/h2>\n<p><strong>Medical Equipment &amp; Devices &#8211; Overnight Price: $6.88 <\/strong><\/p>\n<p>Bell Potter rates ((NAN)) as Sell (5) &#8211;<\/p>\n<p>Nanosonics&#039; stated in its AGM&nbsp;that procedure volumes requiring the use of the Trophon device had largely recovered to pre-covid levels although new installs (a proxy for capital sales of new devices) over the first four months were down by -9% versus last year.<\/p>\n<p>Also, GE Healthcare in North America is planning to resume purchasing capital equipment by the end of the first half given reduced inventory levels. This comes as a surprise to Bell Potter since the company hadn&#039;t disclosed the suspension of purchases.&nbsp;<\/p>\n<p>Since GE is the largest reseller of Trophon in the US market, the broker concludes the absence of regular replenishment orders will likely significantly effect the first-half revenues.&nbsp;<\/p>\n<p>Bell Potter retains its Sell rating with a target of $4.95.<\/p>\n<p>This report was published on November 25, 2020.<\/p>\n<p>Target price is <strong>$4.95<\/strong> Current Price is <strong>$6.88 <\/strong> Difference: <strong>minus $1.93<\/strong> (current price is over target).<br \/>If <strong>NAN<\/strong> meets the Bell Potter target it will return approximately <strong>minus 28%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$5.82<\/strong>, suggesting downside of <strong>-15.5%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.30<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 2293.33<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>3.3<\/strong>, implying annual growth of <strong>-2.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>208.5<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>3.10<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>221.94<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>8.7<\/strong>, implying annual growth of <strong>163.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>1.0<\/strong>, implying a prospective dividend yield of <strong>0.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>79.1<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"NWL\">NWL<\/a>&nbsp;&nbsp;&nbsp; NETWEALTH GROUP LIMITED<\/h2>\n<p><strong>Wealth Management &amp; Investments &#8211; Overnight Price: $16.17 <\/strong><\/p>\n<p>Bell Potter rates ((NWL)) as Hold (3) &#8211;<\/p>\n<p>Netwealth&nbsp;has guided to reach $8bn in platform net-flows for FY21 and reported $1.9 billion in the first quarter. The investment platform retains around 3.8% market share of the platform sector which, Bell Potter indicates,&nbsp;is a significant opportunity to grow<\/p>\n<p>The broker sees Netwealth making continued inroads into the platform sector given the ongoing market dislocation. Earnings growth forecasts for FY21-23&nbsp;upgraded by 2-9-3.5%.<\/p>\n<p>Bell Potter maintains its Hold rating with the target price rising to $17.70 from $17.35.<\/p>\n<p>The report was first published on November 25, 2020.<\/p>\n<p>Target price is <strong>$17.70<\/strong> Current Price is <strong>$16.17 <\/strong> Difference: <strong>$1.53<\/strong><br \/>If <strong>NWL<\/strong> meets the Bell Potter target it will return approximately <strong> 9%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$13.90<\/strong>, suggesting downside of <strong>-14.1%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>18.00<\/strong> cents and EPS of <strong>22.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.11%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>73.50<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>20.9<\/strong>, implying annual growth of <strong>13.8%<\/strong>.<br \/>Current consensus DPS estimate is <strong>16.8<\/strong>, implying a prospective dividend yield of <strong>1.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>77.4<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>22.00<\/strong> cents and EPS of <strong>27.30<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.36%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>59.23<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>25.7<\/strong>, implying annual growth of <strong>23.0%<\/strong>.<br \/>Current consensus DPS estimate is <strong>20.7<\/strong>, implying a prospective dividend yield of <strong>1.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>62.9<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.2<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"NXS\">NXS<\/a>&nbsp;&nbsp;&nbsp; NEXT SCIENCE LIMITED<\/h2>\n<p><strong>Pharmaceuticals &amp; Biotech\/Lifesciences &#8211; Overnight Price: $1.27 <\/strong><\/p>\n<p>Wilsons rates ((NXS)) as Market Weight (3) &#8211;<\/p>\n<p>Wilsons&nbsp;maintains its Market Weight rating with a target of $1.19.<\/p>\n<p>Wilsons is disappointed with the distribution agreement with 3M&#039;s&nbsp;wound care business due to problems during the acute phase of the pandemic, as wound care clinics closed and diverted patients to homecare\/hospice settings.<\/p>\n<p>The Next-3M deal&#039;s early termination gives Next Science scope to reassess some of its own promotional efforts.<\/p>\n<p>Next Science is planning an independent launch for XPerience next year. If approved, the broker notes XPerience will be the only sterile rinse that can be left inside a surgical cavity to prevent biofilm formation and potentially protect against periprosthetic joint infection.<\/p>\n<p>This report was published on November 24, 2020.<\/p>\n<p>Target price is <strong>$1.19<\/strong> Current Price is <strong>$1.27 <\/strong> Difference: <strong>minus $0.08<\/strong> (current price is over target).<br \/>If <strong>NXS<\/strong> meets the Wilsons target it will return approximately <strong>minus 6%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>The company&#039;s fiscal year ends in December.<\/p>\n<p><strong>Forecast for FY20:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY20<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 7.80<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 16.28<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 7.10<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 17.89<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>USD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"PPS\">PPS<\/a>&nbsp;&nbsp;&nbsp; PRAEMIUM LIMITED<\/h2>\n<p><strong>Wealth Management &amp; Investments &#8211; Overnight Price: $0.72 <\/strong><\/p>\n<p>Bell Potter rates ((PPS)) as Buy (1) &#8211;<\/p>\n<p>Bell Potter looks at Praemium in the context of the recent local market gains of above 10% to date in the December quarter, and the positive mark-to-market impact this has on the total funds under management.&nbsp;<\/p>\n<p>The broker believes the key headwinds for Praemium are dissipating and tailwinds appear to be strengthening. The investment platform completed the acquisition of Powerwrap&nbsp;in November and is in the middle of a product\/business integration, which includes $6m in cost-synergies.<\/p>\n<p>The Buy rating is unchanged and the target price is increased to $0.90 from $0.85.<\/p>\n<p>&nbsp;This report was published on November 25, 2020.<\/p>\n<p>Target price is <strong>$0.90<\/strong> Current Price is <strong>$0.72 <\/strong> Difference: <strong>$0.18<\/strong><br \/>If <strong>PPS<\/strong> meets the Bell Potter target it will return approximately <strong> 25%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>1.70<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>42.35<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>1.40<\/strong> cents and EPS of <strong>2.60<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.94%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>27.69<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"TNE\">TNE<\/a>&nbsp;&nbsp;&nbsp; TECHNOLOGYONE LIMITED<\/h2>\n<p><strong>IT &amp; Support &#8211; Overnight Price: $8.79 <\/strong><\/p>\n<p>Bell Potter rates ((TNE)) as Downgrade to Hold from Buy (3) &#8211;<\/p>\n<p>TechnologyOne&#039;s FY20 result was in line with Bell Potter&#039;s forecasts with profit before tax growing by 8% to $82.5m. Revenue grew 4% to $299m, -1% below the broker&#039;s expected $301.6m.&nbsp;The final dividend was up 7% to 9.41c, below the 9.61c expected.<\/p>\n<p>The company did not provide any specific guidance for FY21 although did say it expects strong profit growth to continue&nbsp;led by growth in SaaS recurring revenues and profit.<\/p>\n<p>Bell Potter downgrades its recommendation to Hold from Buy with a target price of $10.00.<\/p>\n<p>This report was published on November 25, 2020.<\/p>\n<p>Target price is <strong>$10.00<\/strong> Current Price is <strong>$8.79 <\/strong> Difference: <strong>$1.21<\/strong><br \/>If <strong>TNE<\/strong> meets the Bell Potter target it will return approximately <strong> 14%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$8.72<\/strong>, suggesting downside of <strong>-0.8%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in September.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>14.20<\/strong> cents and EPS of <strong>22.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.62%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>38.55<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>22.7<\/strong>, implying annual growth of <strong>14.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>15.0<\/strong>, implying a prospective dividend yield of <strong>1.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>38.7<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>16.30<\/strong> cents and EPS of <strong>25.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.85%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>33.94<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>25.0<\/strong>, implying annual growth of <strong>10.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>17.7<\/strong>, implying a prospective dividend yield of <strong>2.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>35.2<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"UWL\">UWL<\/a>&nbsp;&nbsp;&nbsp; UNITI GROUP LIMITED<\/h2>\n<p><strong>Telecommunication &#8211; Overnight Price: $1.44 <\/strong><\/p>\n<p>Canaccord Genuity rates ((UWL)) as Buy (1) &#8211;<\/p>\n<p>Uniti Group&nbsp;acquired a retail service provider Harbour ISP, which specialises in the delivery of high-speed retail broadband services to housing estates and multi-dwelling units.<\/p>\n<p>The acquisition of Harbour comes after the recent acceptance by the ACCC of Uniti&#039;s functional separation undertaking. This undertaking allows&nbsp;the group&nbsp;to be able to operate as both a wholesale and retail provider.<\/p>\n<p>Canaccord Genuity considers the acquisition of Harbour&nbsp;both logical and strategic for Uniti Group as it moves to convert&nbsp;a pipeline of over 215k greenfield&nbsp;premises to active fibre-to-the-premise (FTTP) network connections.<\/p>\n<p>The Buy rating is unchanged and the target rises to $2.15&nbsp;from $2.10.<\/p>\n<p>This report was published on November 20, 2020.<\/p>\n<p>Target price is <strong>$2.15<\/strong> Current Price is <strong>$1.44 <\/strong> Difference: <strong>$0.71<\/strong><br \/>If <strong>UWL<\/strong> meets the Canaccord Genuity target it will return approximately <strong> 49%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>8.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>18.00<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>9.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>16.00<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"WSP\">WSP<\/a>&nbsp;&nbsp;&nbsp; WHISPIR LIMITED<\/h2>\n<p><strong>Cloud services &#8211; Overnight Price: $3.13 <\/strong><\/p>\n<p>Wilsons rates ((WSP)) as Overweight (1) &#8211;<\/p>\n<p>Whispir has updated on its go-to-market for the US including its focus on the high-value, under-serviced SMEs.<\/p>\n<p>Management indicated aspiring towards a&nbsp;goal to earn 50% of its revenue from offshore (30% from the US and 20% from South East Asia).&nbsp;Wilsons believes this could lead to an increase in the group revenue of around 15%, taking its FY23&nbsp;forecasts to circa $95m from from about $82m.<\/p>\n<p>The Overweight rating and target price of $5.10&nbsp;are unchanged.<\/p>\n<p>This report was published on November 19, 2020.<\/p>\n<p>Target price is <strong>$5.10<\/strong> Current Price is <strong>$3.13 <\/strong> Difference: <strong>$1.97<\/strong><br \/>If <strong>WSP<\/strong> meets the Wilsons target it will return approximately <strong> 63%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 7.60<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 41.18<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 2.20<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 142.27<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"Z1P\">Z1P<\/a>&nbsp;&nbsp;&nbsp; ZIP CO LIMITED<\/h2>\n<p><strong>Business &amp; Consumer Credit &#8211; Overnight Price: $5.29 <\/strong><\/p>\n<p>Shaw and Partners rates ((Z1P)) as Buy (1) &#8211;<\/p>\n<p>Quadpay in the US launched a chrome extension to pay-anywhere which&nbsp;allows customers to transact on any website using a form of Quadpay&rsquo;s unique virtual card technology.<\/p>\n<p>Quadpay and Zip Co core products are now available anywhere in their respective countries across apps, browsers and via merchant relationships.<\/p>\n<p>The broker notes Zip has underperformed relative to peers and sits at the bottom of its historical trading range with respect to Afterpay ((APT)). The broker sees a fertile environment in&nbsp;December.<\/p>\n<p>With Quadpay likely to be the fastest-growing US BNPL provider, Shaw and Partners remains bullish and reiterates its Buy rating with a target price of $10.45.<\/p>\n<p>This report was published on November 23, 2020.<\/p>\n<p>Target price is <strong>$10.45<\/strong> Current Price is <strong>$5.29 <\/strong> Difference: <strong>$5.16<\/strong><br \/>If <strong>Z1P<\/strong> meets the Shaw and Partners target it will return approximately <strong> 98%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$6.73<\/strong>, suggesting upside of <strong>27.2%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.20<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 2645.00<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>-11.1<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>N\/A<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.10<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 5290.00<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>-6.4<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>N\/A<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.1<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p><strong>Disclaimer:<\/strong><br \/>The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don&#039;t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.<\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:arial,sans-serif\"><span style=\"font-size:10.0pt\">As part of emerging new trends overseas, The Australian Broker Call *Extra* Edition also includes providers of sponsored research. Readers should bear in mind, sponsored research, while not necessarily of lower quality, has the embedded complication that the company that is the subject of the research has paid for this research. Providers of sponsored research that can potentially be included in this Report are Breakaway Research, Edison Investment Research, Independent Investment Research, NDF Research, Pitt Street Research, and TMT Analytics.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:arial,sans-serif\"><span style=\"font-size:10.0pt\">Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.<\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Extra Edition of the Broker Call Report<\/p>\n","protected":false},"author":8,"featured_media":90557,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[84],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/90551"}],"collection":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/comments?post=90551"}],"version-history":[{"count":0,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/90551\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media\/90557"}],"wp:attachment":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media?parent=90551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/categories?post=90551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/tags?post=90551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}